227 related items for PubMed ID: 1461943
1. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN, Sharma RP, Janicak PG, Davis JM.
Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
[Abstract] [Full Text] [Related]
2. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G, Rihmer Z, Frecska E, Szádóczky E, Arató M.
Psychoneuroendocrinology; 1986 Oct; 11(1):117-20. PubMed ID: 3704065
[Abstract] [Full Text] [Related]
3. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
Pivac N, Mück-Seler D, Jakovljević M.
Neuropsychobiology; 1997 Oct; 36(1):19-21. PubMed ID: 9211439
[Abstract] [Full Text] [Related]
4. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
Meltzer HY, Lowy MT, Locascio JJ.
Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
[Abstract] [Full Text] [Related]
5. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ.
Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
[Abstract] [Full Text] [Related]
6. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.
Pivac N, Jakovljević M, Mück-Seler D, Brzović Z.
Psychiatry Res; 1997 Dec 05; 73(3):123-32. PubMed ID: 9481804
[Abstract] [Full Text] [Related]
7. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
Schweitzer I, Tuckwell VM, Maguire KP, Tiller JW, Harrison LC, Davies BM.
Psychoneuroendocrinology; 1991 Dec 05; 16(5):375-82. PubMed ID: 1805291
[Abstract] [Full Text] [Related]
8. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
Neuropsychobiology; 1998 Dec 05; 37(3):142-5. PubMed ID: 9597670
[Abstract] [Full Text] [Related]
9. Noradrenergic function and the cortisol response to dexamethasone in depression.
Rubin AL, Price LH, Charney DS, Heninger GR.
Psychiatry Res; 1985 May 05; 15(1):5-15. PubMed ID: 2989963
[Abstract] [Full Text] [Related]
10. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ.
Am J Psychiatry; 1983 Sep 05; 140(9):1231-3. PubMed ID: 6614239
[Abstract] [Full Text] [Related]
11. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
Heuser I, Yassouridis A, Holsboer F.
J Psychiatr Res; 1994 Sep 05; 28(4):341-56. PubMed ID: 7877114
[Abstract] [Full Text] [Related]
12. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
Kaneko M, Murata S, Hoshino Y, Takahagi K, Yokoyama F, Watanabe M, Kumashiro H.
Neuropsychobiology; 1994 Sep 05; 24(1):12-6. PubMed ID: 2132636
[Abstract] [Full Text] [Related]
13. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl B, Sherman B, Schlechte J, Stone R.
Arch Gen Psychiatry; 1985 Sep 05; 42(9):897-903. PubMed ID: 2994590
[Abstract] [Full Text] [Related]
14. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, Van Praag HM, Rubinson E, Eisenberg J.
J Affect Disord; 1987 Sep 05; 12(3):219-21. PubMed ID: 2956306
[Abstract] [Full Text] [Related]
15. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
Wahlund B, Sääf J, Wetterberg L.
Acta Psychiatr Scand; 1995 May 05; 91(5):313-21. PubMed ID: 7639087
[Abstract] [Full Text] [Related]
16. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
Thompson LM, Rubin RT, McCracken JT.
Psychoneuroendocrinology; 1992 Oct 05; 17(5):507-15. PubMed ID: 1484917
[Abstract] [Full Text] [Related]
17. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
Mück-Seler D, Pivac N, Jakovljević M, Brzović Z.
Biol Psychiatry; 1999 Jun 01; 45(11):1433-9. PubMed ID: 10356625
[Abstract] [Full Text] [Related]
18. Dexamethasone suppression test in positive and negative schizophrenia.
Altamura C, Guercetti G, Percudani M.
Psychiatry Res; 1989 Oct 01; 30(1):69-75. PubMed ID: 2594873
[Abstract] [Full Text] [Related]
19. The dexamethasone suppression and metyrapone tests in depression.
Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
Psychiatry Res; 1985 Jun 01; 15(2):153-8. PubMed ID: 3862146
[Abstract] [Full Text] [Related]
20. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
Psychoneuroendocrinology; 2016 Jan 01; 63():247-53. PubMed ID: 26519779
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
